1. Corporate Officers - C
2. Chase William J

Insider Trading History of Chase William J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Chase William J since 2016. This trader's CIK number is 1563572. At the time of last reporting, Chase William J was the Officer of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA). Also see all insider trading activities at Intellia Therapeutics, Inc..

Note that in the past CHASE WILLIAM J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Chase William J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2025	NTLA	100,000	$1,002,999	0	$0	0	$0

Yearly summary of insider trading at Abbvie Inc. (ABBV) by Chase William J

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	ABBV	30,400	$2,045,920	0	$0	0	$0
2018	ABBV	0	$0	130,928	$13,711,640	32,400	$850,824
2017	ABBV	0	$0	38,300	$2,502,905	38,300	$1,091,358
2016	ABBV	0	$0	6,600	$390,654	6,600	$180,114

Insider trading activities at 2 companies by Chase William J:

1. Intellia Therapeutics, Inc. (NTLA)

2. Abbvie Inc. (ABBV)

Table 1. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Chase William J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2025-08-20	NTLA	Buy	100,000	10.03	1,002,999

Table 2. Insider trading of Abbvie Inc. (ABBV) by Chase William J

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-06-26	ABBV	Buy	30,400	67.30	2,045,920
2018-12-12	ABBV	Sale	60,000	90.00	5,400,000
2018-03-01	ABBV	Option Ex	32,400	26.26	850,824
2018-02-28	ABBV	Sale	38,528	119.44	4,601,938
2018-03-01	ABBV	Sale	32,400	114.50	3,709,702
2017-05-18	ABBV	Option Ex	38,300	28.50	1,091,358
2017-05-18	ABBV	Sale	38,300	65.35	2,502,905
2016-12-02	ABBV	Sale	6,600	59.19	390,654
2016-12-02	ABBV	Option Ex	6,600	27.29	180,114

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chase William J (Officer of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month